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Volume 56, Number 1 Abstracts 277Ultrasonic Plaque Echolucency and Embolic Signals Predict Stroke in
Asymptomatic Carotid Stenosis
Topakian R, King A, Kwon SU, and the Aces Investigators. Neurology
2011;77:751-8.
Conclusion: Plaque morphology predicts ipsilateral stroke in asymp-
tomatic carotid stenosis (ACS). The combination of embolic signal (ES)
detection and plaque morphology provides greater prediction than either
measure alone and can identify a high-risk group with an annual stroke rate
of 8% and a low-risk group with a stroke rate of 1% per year.
Summary: Intervention for high-grade ACS is increasingly ques-
tioned. There is evidence that, over the last decade, stroke risk with ACS has
fallen with medical intervention alone (Abbott AL, Stroke 2009;40:e573-
83; Marquardt I et al, Stroke 2010;41:e11-7). Nevertheless, although the
percentage of patients with ACS who actually have a stroke is small, most
ipsilateral strokes in patients with carotid stenosis are unheralded (Inzitari D
et al, N Engl J Med 2000;342:1693-700). In this study, the authors
examined the predictive value of a score based on plaque morphology and
detection of ES with transcranial Doppler. Data were derived from the
prospective, observational, international multicenter Asymptomatic Carotid
Emboli Study (ACES). This study included 435 subjects with ACS 70%
with baseline ultrasound images and transcranial Doppler data available.
Prospective follow-up was for 2 years. Plaque morphology was graded using
a classification system proposed by Geroulakos et al (Br J Surg 1993;80:
1274-7). In this system, type 1 plaques are uniformly echolucent, type 2
plaques are predominately echolucent (50% of the plaque), type 3 plaques
are predominately echogenic (50% of the structure of the plaque), type 4
plaques are uniformly echogenic, and type 5 plaques cannot be classified
because of heavy calcification or poor-quality images. Overall, type 1 and
type 2 plaques are considered echolucent and type 3 and 4 plaques echo-
genic. In this study, 164 of the plaques (37.7%) were graded echolucent. At
baseline, plaque echolucency was associated with an increased risk of ipsilat-
eral stroke alone (hazard ratio, 6.43; 95% confidence interval, 1.36-30.44;
P .019). Combining plaque echolucency and ES positivity at baseline was
associated with a marked increased risk of ipsilateral stroke alone (hazard
ratio, 10.61; 95% confidence interval, 2.98-37.82; P  .003). Controlling
for risk factors such as degree of carotid stenosis and antiplatelet medication
did not alter this association.
Comment: Data justifying prophylactic endarterectomy for asymp-
tomatic carotid stenosis is now quite old. Results of surgery, angioplasty, and
medical management of asymptomatic carotid stenosis are likely better now
than a decade or two ago, but at a minimum, 20 carotid interventions for
patients with asymptomatic carotid stenosis are needed to prevent one major
stroke. There clearly needs to be a better approach to selecting patients with
asymptomatic carotid stenosis for prophylactic endarterectomy. However, I
doubt the approach presented here will be the answer. The classification
system of carotid plaques described by Geroulakos et al has been available for
many years and is simply not used, and embolic signal monitoring, as
performed in the ACES study, is too cumbersome to be incorporated into
routine clinical practice.
Asymptomatic Carotid Artery Stenosis and Cognitive Outcomes After
Coronary Artery Bypass Grafting
Norkienë I, Samalavic`ius R, Ivaškevicˇius J, et al. Scand Cardiovasc J 2011;
45:169-73.
Conclusion: Asymptomatic 50% carotid stenosis is a risk factor for
cognitive decline after coronary artery bypass grafting (CABG).
Summary: Patients anticipate CABG will improve their quality of life
(Koch CG et al, Semin Cardiothorac Vasc Anesth 2008;12:203-17). Pres-
ervation and improvement of psychologic emotional well-being enhances
quality of life. Neuropsychologic disorders are being more frequently ad-
dressed in the care of the postoperative patient. Cerebrovascular disease and
coronary artery disease potentially put patients at risk for cognitive decline.
In this report, the authors correlate asymptomatic carotid stenosis with
cognitive decline after coronary artery bypass grafting (CABG). They sought
to detect the incidence of cognitive decline after CABG, identify risk factors
associated with such cognitive decline, and investigate a possible link be-
tween cognitive performance and asymptomatic carotid stenosis.
The authors studied 127 patients who underwent CABG. The patients
underwent a neuropsychologic examination that included seven cognitive
tests and two scales for evaluation of mood disorders. The patients were
tested the day before surgery and before discharge from the hospital. Testing
revealed that early postoperative decline was common and was detected in
46% of patients. Postoperative cognitive decline was associated with low
cardiac output syndrome perioperatively (P  .05), postoperative bleeding
(P  .03), longer duration of surgery (P  .02), and longer intensive care
unit stay and postoperative mechanical ventilation time (P .05). Multivar-
iate regression analysis indicated carotid artery stenosis of50%was a strong
independent predictor of postoperative cognitive decline (odds ratio, 26.9;
95% confidence interval, 6.44-112.34).Comment: The authors’ data indicate an association between cogni-
tive decline after CABG and the presence of 50% carotid stenosis. One
r
oannot, however, derive from this data that the carotid stenosis itself leads
o cognitive decline after CABG. Indeed, we know that repair of asymptom-
tic carotid stenosis before CABG has minimal, if any, impact on more
bvious clinical end points such as stroke and death after CABG. This study
id not have cerebral imaging before and after CABG to correlate with the
europhysiologic testing. At this time, it seems more likely the carotid
tenosis is more of a marker for more advanced preexisting intracranial
ascular disease potentially associated with cognitive decline after CABG
han a potential target for intervention to decrease cognitive decline after
ABG.
ystematic Review of Exercise Training or Percutaneous Transluminal
ngioplasty for Intermittent Claudication
rans FA, Bipat S, Reekers JA, et al. Br J Surg 2012;99:16-28.
Conclusion: The combination of percutaneous transluminal angio-
lasty (PTA) and exercise therapy (ET) may be superior to ET or PTA alone
or treatment of intermittent claudication.
Summary: One goal in patients with intermittent claudication is to
mprove walking distance with the thought that improved walking distance
ill improve quality of life. PTA, surgery, drugs, and ET all potentially
mprove symptoms in patients with intermittent claudication. Systematic
eviews have demonstrated superiority of supervised ET (SET) over unsu-
ervised ET for increasing pain-free and maximum walking distance (Ben-
ermacher BL et al, Cochrane Database Syst Rev 2006;CD005263; Wind J
t al, Eur J Vasc Endovasc Surg 2007;34:1-9). A Cochran review (Fowkes
G et al, Cochrane Database Syst Rev 2000;CD000017) indicted greater
hort-term benefit with PTA than ET in patients with intermittent claudi-
ation, but that the effect was not sustained after 1 to 2 years. A second
eview found medical treatment (home or SET, plus risk factor modifica-
ion) resulted in longer walking distances than PTA at 1 to 2 years (Wilson
E, Ann Vasc Surg 2010;24:498-502). The authors noted that since this
eview, six additional randomized clinical trials have compared PTA and ET.
hey performed a systematic review to summarize the results of all currently
vailable randomized clinical trials comparing PTA with ET therapy, with
he goal to obtain the best estimate of the relative effectiveness of PTA and
T.
This was a systematic review of relevant randomized clinical trials
dentified from the MEDLINE, Embase, and Cochrane Library Databases.
o be included in the review, the trial had to compare PTA with ET in
atients with intermittent claudication secondary to aortoiliac or femoral
opliteal occlusive disease, or both. There were 258 initial articles identified,
ith 11 (reporting data on eight trials) meeting inclusion criteria, including
ne trial with isolated aortoiliac obstruction, three trials with femoropopli-
eal disease, and five with combined lesions. Two trials compared PTA with
dvice for ET, four trials compared PTA with SET, two trials compared PTA
lus SET with SET alone, and two trials compared PTA plus SET with PTA
lone. The authors concluded that heterogeneity precluded pooling of the
ata even though the end points in most trials were walking distance and
uality of life. Their analysis indicated the effectiveness of PTA and ET was
quivalent, although PTA plus ET provided greater improvement of walking
istance and some domains of quality of life analysis compared with PTA
lone or ET alone.
Comment: The article provides the most up-to-date information on
he effectiveness of ET and PTA for treatment of intermittent claudication.
ET and PTA can both be effective in improving walking distance in patients
ith claudication. Neither therapy is perfect. ET is noninvasive, relatively
nexpensive, and has less risk compared with PTA. However, PTA may be
ore universally applicable and more quickly effective. Eventual failure rates
re high with PTA, but angioplasty of infrainguinal arteries is a moving
arget, with potential improvements of percutaneous techniques such as
rug-eluting balloons and stents shortly down the road. Two important
uestions not addressed in this study include the cost-effectiveness of each
reatment strategy and the potential for each treatment strategy to convert
atients from claudication to critical limb ischemia with therapy failure.
tenting Versus Surgery in PatientsWith Carotid Stenosis After Previous
ervical Radiation Therapy: Systematic Review and Meta-Analysis
okkema M, den Hartog AG, Bots ML. Stroke 2012;43:793-801.
Conclusions: In patients with carotid stenosis after previous cervical
adiation therapy, carotid artery stenting (CAS) and carotid endarterectomy
CEA) are both feasible revascularization techniques with a low risk of
erebral vascular events. Patients undergoing CEA have more temporary
ranial nerve injuries. There are higher rates of late adverse cerebral vascular
vents and restenosis after CAS than CEA.
Summary: CAS is proposed as a minimally invasive alternative for
atients considered high risk for perioprocedural events with CEA. Patients
ay be high risk from anatomic or clinical factors. One anatomic factor
onsidered by some to impart increased risk for CEA is previous cervical
adiation therapy. However, previous radiation therapy may accelerate rates
f restenosis and subsequent cerebral events in patients treated with CAS or
